SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for BIO-PATH HOLDINGS, INC. (BPTH) (CIK 0001133818) (BPTH) — Jan 30, 2013

BIO-PATH HOLDINGS, INC. (BPTH) (CIK 0001133818)
Date: Jan. 30, 2013 · CIK: 0001133818 · Accession: 0000000000-13-005472

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
December 31, 2011
Author
/s/ Mara L. Ransom
Form
UPLOAD
Company
BIO-PATH HOLDINGS, INC. (BPTH) (CIK 0001133818)

Letter

January 30, 201 3 Via E -mail Peter H. Nielsen President and Chief Executive Officer Bio-Path Holdings, Inc. 2626 South Loop, Suite 180 Houston , TX 77054

Re: Bio-Path Holdings, Inc. Form 10 -K for Fiscal Year Ended December 31, 2011 Filed March 30 , 2012 File No. 000 -53404

Dear Mr. Nielsen :

We have completed our review of your filings . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing s and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securiti es laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing s to be certain that the filing s include the information the Securities Exchange Act of 1934 and all applicable rules requir e.

Sincerely,
/s/ Mara L. Ransom

Show Raw Text
January 30, 201 3

Via E -mail
Peter H. Nielsen
President and Chief Executive Officer
Bio-Path Holdings, Inc.
2626 South Loop, Suite 180
Houston , TX  77054

Re: Bio-Path Holdings, Inc.
 Form 10 -K for Fiscal Year Ended December 31, 2011
 Filed March 30 , 2012
File No. 000 -53404

Dear Mr. Nielsen :

We have completed our review of your filings .  We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the Commission from taking
any action with respect to the company or the filing s and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any person under the
federal securiti es laws of the United States.  We urge all persons who are responsible for the
accuracy and adequacy of the disclosure in the filing s to be certain that the filing s include the
information the Securities Exchange Act of 1934 and all applicable rules requir e.

Sincerely,

 /s/ Mara L. Ransom

Mara L. Ransom
Assistant Director